ANA Therapeutics

ANA Therapeutics is a biotechnology company that specializes in developing innovative treatments for infectious diseases. The company's focus is on creating therapies that target the host response to infections, rather than the pathogens themselves. This approach is aimed at reducing the development of drug-resistant strains of viruses and bacteria. ANA Therapeutics has a pipeline of drug candidates targeting various viral infections, including COVID-19, as well as bacterial infections caused by multi-drug resistant organisms. The company's mission is to provide safe and effective treatments for infectious diseases that have a significant impact on global health.